FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1345032007: Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5389610010 Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5389611014 Cytarabine liposome 100 mg and daunorubicin liposome 44 mg powder for solution for infusion vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Is a Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form Powder for conventional release solution for infusion (dose form) true Inferred relationship Some
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation Vial (unit of presentation) true Inferred relationship Some
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient Cytarabine liposome true Inferred relationship Some 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) Cytarabine liposome true Inferred relationship Some 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Some 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient Daunorubicin liposome (substance) true Inferred relationship Some 2
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) Daunorubicin liposome (substance) true Inferred relationship Some 2
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start